Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
Department of Emergency Medicine, University of Mississippi Medical Center, Jackson, Mississippi.
Am J Physiol Renal Physiol. 2020 Apr 1;318(4):F911-F921. doi: 10.1152/ajprenal.00438.2019. Epub 2020 Feb 18.
The present study examined whether development of renal injury in the nondiabetic obese Dahl salt-sensitive leptin receptor mutant (SSmutant) strain is associated with elevations in glomerular filtration rate and renal lipid accumulation. Baseline mean arterial pressure at 6 wk of age was similar between Dahl salt-sensitive wild-type (SS) and SSmutant rats. However, by 18 wk of age, the SSmutant strain developed hypertension, while the elevation in mean arterial pressure was not as severe in SS rats (192 ± 4 and 149 ± 6 mmHg, respectively). At baseline, proteinuria was fourfold higher in SSmutant than SS rats and remained elevated throughout the study. The early development of progressive proteinuria was associated with renal hyperfiltration followed by a decline in renal function over the course of study in the SSmutant compared with SS rats. Kidneys from the SSmutant strain displayed more glomerulosclerosis and glomerular lipid accumulation than SS rats. Glomeruli were isolated from the renal cortex of both strains at 6 and 18 wk of age, and RNA sequencing was performed to identify genes and pathways driving glomerular injury. We observed significant increases in expression of the influx lipid transporters, chemokine (C-X-C motif) ligand 16 (Cxcl16) and scavenger receptor and fatty acid translocase (Cd36), respectively, and a significant decrease in expression of the efflux lipid transporter, ATP-binding cassette subfamily A member 2 (; cholesterol efflux regulatory protein 2), in SSmutant compared with SS rats at 6 and 18 wk of age, which were validated by RT-PCR analysis. These data suggest an association between glomerular hyperfiltration and glomerular lipid accumulation during the early development of proteinuria associated with obesity.
本研究旨在探讨非糖尿病肥胖型 Dahl 盐敏感型瘦素受体突变(SSmutant)大鼠的肾脏损伤是否与肾小球滤过率升高和肾脏脂质积累有关。6 周龄时,Dahl 盐敏感型野生型(SS)和 SSmutant 大鼠的平均动脉压基线相似。然而,到 18 周龄时,SSmutant 大鼠出现高血压,而 SS 大鼠的平均动脉压升高并不那么严重(分别为 192±4 和 149±6mmHg)。在基线时,SSmutant 大鼠的蛋白尿是 SS 大鼠的四倍,并且在整个研究过程中一直保持升高。与 SS 大鼠相比,SSmutant 大鼠在研究过程中早期发生进行性蛋白尿,随后肾功能下降。与 SS 大鼠相比,SSmutant 大鼠肾脏显示出更多的肾小球硬化和肾小球脂质积累。在 6 和 18 周龄时,从两种品系的肾脏皮质中分离出肾小球,并进行 RNA 测序以鉴定导致肾小球损伤的基因和途径。我们观察到,在 SSmutant 大鼠中,流入脂质转运蛋白(趋化因子(C-X-C 基序)配体 16(Cxcl16)和清道夫受体和脂肪酸转运蛋白(Cd36)的表达分别显著增加,而流出脂质转运蛋白(ATP 结合盒亚家族 A 成员 2(;胆固醇外排调节蛋白 2)的表达显著降低,与 6 和 18 周龄时的 SS 大鼠相比,这些结果通过 RT-PCR 分析得到验证。这些数据表明,在肥胖相关蛋白尿早期发展过程中,肾小球高滤过与肾小球脂质积累之间存在关联。